Thinking up tomorrow's medicine
ONE Study, a research program of the CESTI University Hospital Institute, applies the innovative concept of cell therapy in the field of organ transplantation. A clinical trial based on this therapy and which aims at limiting the side effects of anti -rejection treatments will start in Nantes by the end of the year.
Oncotherex offers innovative technology to improve drug development and personalized treatment of patients with breast cancer (1.5 million patients worldwide, + 50% by 2030) and ovarian cancer (240,000 patients worldwide, + 43% by 2030). Oncotherex is incubated by Atlanpole and accompanied by Angers Technopole.
VitamFero is a company developing novel anti-infective (notably anti-parasitics) prophylactic applications in animal health. It has just secured an icrease in new capital increase to the sum of €2,7 million with Go Capital (through the West Ventures II Fund), Pradeyrol Développement and Business Angels, which is affiliated with Val de France Angels, in partnership with the original shareholders. VitamFero is a member of Atlanpole Biotherapies competitive cluster.
NEOSTEO is a French innovative startup specialized in the development, production and marketing of advanced implant solutions aimed at simplifying orthopedic and trauma surgery. NEOSTEO offers a smart implant line of Osteotomy Solutions to treat knee arthrosis deformities. The SME wanted to collaborate through the IN2LifeSciences network, to evaluate its “FlexitSystem” solution by measuring stability and strength of the high tibial osteotomy.
[Press Release] The Genotrace project, combining targeted research and technology transfer1, aims at delivering an innovative test to improve the safety of chemical products, drugs, human and animal food and the environment. The project consortium is led by INRA (French National Institute for Agricultural Research) and includes CNRS (French National Center for Scientific Research), the University Toulouse III – Paul Sabatier and the company Biopredic International. The Genotrace project has just received the support of the French National Research Agency (ANR) for three years.
Business creations, patents, recruitment ... The European Transplantation and Immunotherapy Science Center shows concrete results for two years. It is now carrying about twenty research projects of which Atlanpole Biotherapies will offer a monthly decoding. Next month, you will find out about the "One Study" project, a clinical trial about cellular immunotherapy in transplantation in man.
From 10 to 13 June, a dozen foreign students, selected on the basis of their motivation to put a value on their research, took part in an accelerated training in Nantes. They were led by professionals, to be enabled to create their start-up business. This multicultural group (from England, Eastern Europe, Sweden, China ...) working in the field of biotechnology, studied the themes of intellectual property, finance and funding sources, and finally produced a trial presentation.
Dentaurum Ceramics is the ceramic research and manufacturing center of the Group Dentaurum GmbH and Co.KG, one of the European leaders in orthodontics and dentures. Established since 1994, in France near Angers, Dentaurum Ceramics develops and produces the Dentaurum group’s entire range of dental ceramics.
December 2-3: The SIMV organizes the first R&D dating for Animal Health and Innovation in Lille (Grand Palais)
The French association of animal health industry (SIMV) organizes the first R&D dating for animal health and innovation on December 2nd and 3rd 2014 in Lille, hosted within BioFIT. These meetings aim to initiate high-level exchanges between teams from private and public research and biotechnology companies, in veterinary and human medicine in France and Europe. These meetings are organized in partnership with the Animal Health Carnot Institute, Eurasanté, Medicen Paris Region, the French Alliance for Research and Innovation in health industries and the Companies for Accelerating the Technology Transfer1. Many other organizations provide support, Atlanpole Biotherapies is one of them.
Join our members in the field of biomaterials at the next meeting of the European project “Biomat-In” on Biomaterials which is organized in Lille for December 3, 2014 on the theme "Biomaterials for wound healing". Come and meet them !
BioFit is the first European business convention entirely dedicated to Open Innovation, technology transfer and collaborative research in the field of Life Sciences. This international event brings together all professionals in the chain of innovation in the field of Life Sciences (start-up companies, academic research, private research, large companies ...) and thus promotes collaborative public / private R & D projects, and an increase in the number of licensing agreements.
The Atlanpole Biotherapies competitive cluster combines the expertise of laboratories, companies and technical departments for a public-private offer of services, comprehensive, relevant and competitive, in the value chain of bio-medicine from target discovery to clinical evaluation.
Our ambition is to become a reference center on an international scale for the development of diagnostic and therapeutic solutions in the field of biotherapies.
Atlanpole Biotherapies is a competitive cluster certified by the Ministry of Industry (July 2005).